Kim M, Ahn JM, Kang DY, Kim MJ, et al. Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial. Am Heart J 2024;269:167-178.
PMID: 38123045